These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2505707)

  • 1. [Hypertension and the renin-angiotensin system. The role of perindopril. 1st international Coversyl symposium. Paris, 29 October 1988. Proceedings].
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():1-94. PubMed ID: 2505707
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension, the renin-angiotensin system and perindopril. First International Symposium on Perindopril. Paris, France, October 29, 1989.
    Clin Exp Hypertens A; 1989; 11 Suppl 2():459-623. PubMed ID: 2605797
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension and the renin-angiotensin system. The place of perindopril. Conclusions.
    Guedon J
    Clin Exp Hypertens A; 1989; 11 Suppl 2():619-23. PubMed ID: 2605802
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues].
    Med Clin (Barc); 1991 Apr; 96(16):suppl 2 p.. PubMed ID: 2051826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antihypertensive effect of perindopril. Experimental pharmacology].
    Barthelmebs M; Devissaguet M; Imbs JL
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():17-24. PubMed ID: 2505709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of perindopril (prestarium) in arterial hypertension].
    Filatova NP
    Ter Arkh; 1995; 67(9):81-3. PubMed ID: 7495054
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [International experts commented on the characteristics of perindopril, a new highly potent and well tolerated ACE. Perindopril has been able to reduce the thickness and rigidity of the arterial wall in animal studies].
    Med Clin (Barc); 1991 May; 96(19):suppl 2 p.. PubMed ID: 1875747
    [No Abstract]   [Full Text] [Related]  

  • 9. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of perindopril on hypertension, serum angiotensin-I-converting enzyme activity and urine level of N-acetyl-beta-D-glucosaminidase].
    Wang Z; Li Y; Zhou Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):233-6. PubMed ID: 9868122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychotropic effects of angiotensin-converting enzyme inhibitors: what are the arguments?].
    Mesure G; Fallet A; Chevalier JF
    Encephale; 1995; 21(5):609-14. PubMed ID: 8529571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
    Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T
    Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From vascular protection to secondary prevention in cardiovascular diseases. Proceedings of satellite symposium to the 16th Scientific Meeting of the International Society of Hypertension. Glasgow, United Kingdom, 23 June 1996.
    J Hypertens Suppl; 1996 Dec; 14(6):S1-53. PubMed ID: 9091612
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring.
    Asmar RG; Pannier BM; Santoni JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S79-81. PubMed ID: 3225692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral effects of perindopril in essential hypertension.
    Sagnella GA; Markandu ND; Singer DR; Buckley MG; Miller MA; MacGregor GA
    Eur J Clin Pharmacol; 1991; 41(6):625-6. PubMed ID: 1815981
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific properties and effect of perindopril in controlling the renin-angiotensin system.
    Ferrari R; Pasanisi G; Notarstefano P; Campo G; Gardini E; Ceconi C
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):142S-154S. PubMed ID: 16125051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.
    Santoni JP; Asmar R; Safar ME
    Clin Exp Hypertens A; 1989; 11 Suppl 2():535-44. PubMed ID: 2691127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ACE inhibitors in current clinical practice. The place of perindopril: a review. Proceedings of two symposia. 8 November and 15 November, 1989.
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():1-73. PubMed ID: 1980931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.